Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Product safety - Unauthorized product
What you should do
- Only buy prescription drugs from a licensed pharmacy.
- Do not buy or use unauthorized products.
- Look for drugs that have been authorized by Health Canada by checking for the eight-digit Drug Identification Number (DIN) on the label and by searching Health Canada's Drug Product Database.
- Speak with your healthcare professional if you have used an unauthorized GLP-1 product and have concerns about your health.
- Know the risks of buying drugs over the Internet and know how to choose a safe online pharmacy.
- Report any health product-related side effects or complaints, including suspected counterfeit and unauthorized products, to Health Canada.
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
2026-11-06
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.